| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.872 | 0.007 | 0.872 | Antiinflammatory | 0.851 0.009 DBMET00218 0.867 0.008 DBMET00219 | ||
| 0.786 | 0.002 | 0.786 | Uric acid excretion stimulant | 0.683 0.003 DBMET00218 0.479 0.004 DBMET00219 | ||
| 0.727 | 0.005 | 0.727 | Platelet antagonist | 0.389 0.029 DBMET00218 0.354 0.037 DBMET00219 | ||
| 0.693 | 0.008 | 0.693 | Thioredoxin glutathione reductase inhibitor | 0.575 0.018 DBMET00218 0.652 0.011 DBMET00219 | ||
| 0.675 | 0.016 | 0.77 | Analgesic | 0.663 0.017 DBMET00218 0.77 0.008 DBMET00219 | DBMET00219 | |
| 0.646 | 0.004 | 0.646 | P-glycoprotein inhibitor | 0.269 0.036 DBMET00218 0.203 0.062 DBMET00219 | ||
| 0.614 | 0.015 | 0.614 | Antithrombotic | 0.534 0.025 DBMET00218 0.443 0.039 DBMET00219 | ||
| 0.601 | 0.005 | 0.601 | Platelet aggregation inhibitor | 0.428 0.015 DBMET00218 0.369 0.023 DBMET00219 | ||
| 0.546 | 0.004 | 0.668 | Cyclooxygenase inhibitor | 0.388 0.008 DBMET00218 0.668 0.004 DBMET00219 | DBMET00219 | |
| 0.524 | 0.005 | 0.693 | Cyclooxygenase 1 inhibitor | 0.299 0.014 DBMET00218 0.693 0.004 DBMET00219 | DBMET00219 | |
| 0.515 | 0.006 | 0.515 | Non-steroidal antiinflammatory agent | 0.357 0.019 DBMET00218 0.477 0.008 DBMET00219 | ||
| 0.465 | 0.005 | 0.465 | Interleukin 1 antagonist | |||
| 0.42 | 0.005 | 0.42 | Peptidyltransferase inhibitor | 0.163 0.162 DBMET00219 | ||
| 0.412 | 0.007 | 0.412 | Interleukin 6 antagonist | |||
| 0.376 | 0.019 | 0.376 | Anticoagulant | 0.242 0.04 DBMET00218 0.285 0.031 DBMET00219 | ||
| 0.34 | 0.005 | 0.426 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.426 0.003 DBMET00218 0.34 0.005 DBMET00219 | DBMET00218 | |
| 0.359 | 0.031 | 0.359 | Vasodilator | |||
| 0.362 | 0.037 | 0.362 | Interleukin antagonist | |||
| 0.397 | 0.092 | 0.493 | Cyclophilin D inhibitor | 0.342 0.128 DBMET00218 0.493 0.052 DBMET00219 | DBMET00219 | |
| 0.376 | 0.074 | 0.424 | Prostaglandin dehydrogenase inhibitor | 0.424 0.06 DBMET00218 | DBMET00218 | |
| 0.348 | 0.051 | 0.348 | Calcium channel activator | 0.223 0.181 DBMET00218 | ||
| 0.27 | 0.017 | 0.449 | Cyclooxygenase 2 inhibitor | 0.22 0.026 DBMET00218 0.449 0.004 DBMET00219 | DBMET00219 | |
| 0.255 | 0.012 | 0.255 | Interleukin 1b antagonist | |||
| 0.235 | 0.017 | 0.235 | Death-associated protein kinase 2 inhibitor | |||
| 0.233 | 0.028 | 0.233 | Phospholipase A2 inhibitor | 0.203 0.041 DBMET00218 0.186 0.051 DBMET00219 | ||
| 0.207 | 0.021 | 0.207 | MAP kinase 12 inhibitor | |||
| 0.185 | 0.01 | 0.214 | Electrolyte absorption antagonist | 0.214 0.007 DBMET00218 0.185 0.01 DBMET00219 | DBMET00218 | |
| 0.159 | 0.009 | 0.159 | Prostaglandin antagonist | 0.065 0.029 DBMET00219 | ||
| 0.153 | 0.005 | 0.153 | H+/K+-transporting ATPase inhibitor | |||
| 0.276 | 0.138 | 0.285 | Histamine release inhibitor | 0.285 0.132 DBMET00218 | DBMET00218 | |
| 0.165 | 0.03 | 0.165 | MAP kinase 13 inhibitor | |||
| 0.226 | 0.102 | 0.226 | 5 Hydroxytryptamine release stimulant | 0.173 0.149 DBMET00219 | ||
| 0.211 | 0.087 | 0.211 | Hypolipemic | |||
| 0.124 | 0.005 | 0.124 | CC chemokine 5 receptor antagonist | |||
| 0.22 | 0.117 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.325 0.034 DBMET00218 0.22 0.117 DBMET00219 | DBMET00218 | |
| 0.181 | 0.104 | 0.213 | 5 Hydroxytryptamine 3E antagonist | 0.213 0.043 DBMET00218 0.181 0.104 DBMET00219 | DBMET00218 | |
| 0.1 | 0.024 | 0.1 | Viral attachment inhibitor | |||
| 0.083 | 0.021 | 0.083 | Exportin-1 inhibitor | |||
| 0.125 | 0.064 | 0.125 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.1 DBMET00218 0.115 0.082 DBMET00219 | ||
| 0.229 | 0.178 | 0.229 | Antiobesity | |||
| 0.199 | 0.15 | 0.226 | Gastrin inhibitor | 0.226 0.111 DBMET00218 0.186 0.17 DBMET00219 | DBMET00218 | |
| 0.061 | 0.023 | 0.065 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.065 0.021 DBMET00219 | DBMET00219 | |
| 0.107 | 0.072 | 0.162 | Acetylcholine release stimulant | 0.162 0.01 DBMET00218 0.104 0.078 DBMET00219 | DBMET00218 | |
| 0.148 | 0.115 | 0.163 | Succinate dehydrogenase inhibitor | 0.163 0.09 DBMET00218 0.148 0.115 DBMET00219 | DBMET00218 | |
| 0.082 | 0.049 | 0.082 | CC chemokine receptor antagonist | |||
| 0.067 | 0.036 | 0.067 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET00219 | ||
| 0.079 | 0.049 | 0.079 | MAP kinase 11 inhibitor | |||
| 0.04 | 0.012 | 0.069 | Prostaglandin D2 agonist | 0.069 0.004 DBMET00218 0.038 0.014 DBMET00219 | DBMET00218 | |
| 0.042 | 0.015 | 0.042 | Histone deacetylase 10 inhibitor | |||
| 0.039 | 0.012 | 0.039 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.122 | 0.097 | 0.181 | Cell wall synthesis inhibitor | 0.181 0.039 DBMET00218 | DBMET00218 | |
| 0.152 | 0.128 | 0.152 | EphB2 antagonist | |||
| 0.186 | 0.163 | 0.268 | Tyrosine 3 hydroxylase inhibitor | 0.203 0.13 DBMET00218 0.268 0.052 DBMET00219 | DBMET00219 | |
| 0.057 | 0.035 | 0.057 | Thromboxane antagonist | 0.05 0.042 DBMET00218 0.054 0.037 DBMET00219 | ||
| 0.053 | 0.033 | 0.053 | Thromboxane A2 antagonist | 0.046 0.04 DBMET00218 0.049 0.037 DBMET00219 | ||
| 0.037 | 0.018 | 0.037 | Histone deacetylase 11 inhibitor | |||
| 0.037 | 0.018 | 0.037 | Histone deacetylase class IV inhibitor | |||
| 0.08 | 0.064 | 0.121 | CC chemokine 5 receptor agonist | 0.087 0.043 DBMET00218 0.121 0.008 DBMET00219 | DBMET00219 | |
| 0.021 | 0.008 | 0.021 | CXC chemokine 5 receptor antagonist | 0.018 0.012 DBMET00219 | ||
| 0.053 | 0.042 | 0.053 | Dihydroorotate oxidase inhibitor | |||
| 0.066 | 0.055 | 0.066 | CXC chemokine receptor antagonist | |||
| 0.031 | 0.023 | 0.031 | Histone deacetylase 4 inhibitor | |||
| 0.047 | 0.041 | 0.047 | Prolyl endopeptidase inhibitor | |||
| 0.029 | 0.023 | 0.029 | Peptide deformylase inhibitor | |||
| 0.034 | 0.029 | 0.034 | Histone deacetylase 7 inhibitor | |||
| 0.031 | 0.029 | 0.037 | Glucose-dependent insulinotropic receptor agonist | 0.037 0.021 DBMET00219 | DBMET00219 | |
| 0.084 | 0.082 | 0.084 | Chemokine receptor antagonist | |||
| 0.083 | 0.082 | 0.096 | Creatine kinase inhibitor | 0.096 0.064 DBMET00218 0.083 0.082 DBMET00219 | DBMET00218 | |
| 0.036 | 0.035 | 0.036 | Histone deacetylase 9 inhibitor | |||
| 0.049 | 0.051 | 0.205 | DNA helicase inhibitor | 0.074 0.014 DBMET00218 0.205 0.002 DBMET00219 | DBMET00219 | |
| 0.173 | 0.176 | 0.184 | Neuropeptide Y2 antagonist | 0.184 0.151 DBMET00218 | DBMET00218 | |
| 0.087 | 0.094 | 0.1 | Adenylate kinase inhibitor | 0.1 0.067 DBMET00218 | DBMET00218 | |
| 0.035 | 0.045 | 0.047 | Histamine H2 receptor agonist | 0.047 0.025 DBMET00218 | DBMET00218 | |
| 0.08 | 0.095 | 0.104 | GABA C receptor agonist | 0.104 0.063 DBMET00218 | DBMET00218 | |
| 0.026 | 0.043 | 0.034 | G protein-coupled receptor agonist | 0.034 0.03 DBMET00219 | DBMET00219 | |
| 0.017 | 0.043 | 0.028 | Prostaglandin EP3 antagonist | 0.028 0.023 DBMET00218 | DBMET00218 | |
| 0.069 | 0.096 | 0.088 | Aminopeptidase B inhibitor | 0.088 0.074 DBMET00218 | DBMET00218 | |
| 0.043 | 0.074 | 0.101 | Collagenase 3 inhibitor | 0.066 0.035 DBMET00218 0.101 0.015 DBMET00219 | DBMET00219 | |
| 0.172 | 0.204 | 0.242 | Insulysin inhibitor | 0.221 0.127 DBMET00218 0.242 0.104 DBMET00219 | DBMET00219 | |
| 0.104 | 0.136 | 0.196 | Mannose-6-phosphate isomerase inhibitor | 0.196 0.033 DBMET00218 0.142 0.072 DBMET00219 | DBMET00218 | |
| 0.032 | 0.069 | 0.084 | Carbonic anhydrase II inhibitor | 0.05 0.044 DBMET00218 0.084 0.024 DBMET00219 | DBMET00219 | |
| 0.04 | 0.079 | 0.075 | Androgen agonist | 0.075 0.027 DBMET00218 | DBMET00218 | |
| 0.028 | 0.068 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.031 DBMET00218 | DBMET00218 | |
| 0.041 | 0.082 | 0.053 | Angiotensin-converting enzyme inhibitor | 0.053 0.041 DBMET00218 | DBMET00218 | |
| 0.194 | 0.236 | 0.397 | Antibacterial | 0.397 0.078 DBMET00218 | DBMET00218 | |
| 0.071 | 0.114 | 0.098 | Ferrochelatase inhibitor | 0.098 0.073 DBMET00218 | DBMET00218 | |
| 0.01 | 0.056 | 0.024 | Hexokinase stimulant | 0.024 0.011 DBMET00219 | DBMET00219 | |
| 0.033 | 0.084 | 0.096 | Carbonic anhydrase inhibitor | 0.058 0.047 DBMET00218 0.096 0.028 DBMET00219 | DBMET00219 | |
| 0.151 | 0.202 | 0.211 | Lipoxygenase inhibitor | 0.211 0.129 DBMET00218 | DBMET00218 | |
| 0.023 | 0.079 | 0.04 | Membrane dipeptidase inhibitor | 0.04 0.027 DBMET00218 | DBMET00218 | |
| 0.045 | 0.103 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 DBMET00218 | DBMET00218 | |
| 0.013 | 0.073 | 0.03 | Prostaglandin agonist | 0.03 0.023 DBMET00218 | DBMET00218 | |
| 0.09 | 0.152 | 0.137 | Antibacterial (Helicobacter pylori) | 0.137 0.059 DBMET00218 | DBMET00218 | |
| 0.029 | 0.094 | 0.066 | Cathepsin L inhibitor | 0.066 0.033 DBMET00219 | DBMET00219 | |
| 0.176 | 0.242 | 0.231 | GABA C receptor rho-3 antagonist | 0.231 0.172 DBMET00218 | DBMET00218 | |
| 0.083 | 0.148 | 0.134 | Cathepsin H inhibitor | 0.134 0.06 DBMET00219 | DBMET00219 | |
| 0.128 | 0.196 | 0.184 | Histone acetyltransferase inhibitor | 0.184 0.093 DBMET00218 0.15 0.139 DBMET00219 | DBMET00218 | |
| 0.058 | 0.128 | 0.092 | Antihistaminic | 0.092 0.062 DBMET00218 | DBMET00218 | |
| 0.096 | 0.167 | 0.134 | Arachidonic acid antagonist | 0.134 0.108 DBMET00218 | DBMET00218 | |
| 0.048 | 0.125 | 0.093 | Metalloproteinase-9 inhibitor | 0.093 0.036 DBMET00219 | DBMET00219 | |
| 0.053 | 0.131 | 0.073 | MDM2 inhibitor | 0.073 0.031 DBMET00219 | DBMET00219 | |
| 0.048 | 0.127 | 0.081 | Histamine antagonist | 0.081 0.062 DBMET00218 | DBMET00218 | |
| 0.02 | 0.1 | 0.061 | Carbonic anhydrase VB inhibitor | 0.061 0.034 DBMET00218 0.057 0.038 DBMET00219 | DBMET00218 | |
| 0.054 | 0.136 | 0.071 | Vanilloid 4 agonist | 0.071 0.06 DBMET00218 | DBMET00218 | |
| 0.033 | 0.115 | 0.087 | Matrix metalloproteinase inhibitor | 0.087 0.033 DBMET00219 | DBMET00219 | |
| 0.021 | 0.108 | 0.108 | Cannabinoid CB2 receptor agonist | 0.108 0.017 DBMET00219 | DBMET00219 | |
| 0.027 | 0.126 | 0.05 | Aldosterone antagonist | 0.05 0.029 DBMET00219 | DBMET00219 | |
| 0.046 | 0.15 | 0.075 | Carbonic anhydrase VI inhibitor | 0.075 0.064 DBMET00219 | DBMET00219 | |
| 0.099 | 0.204 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.071 DBMET00219 | DBMET00219 | |
| 0.107 | 0.221 | 0.199 | Spasmolytic | 0.199 0.12 DBMET00219 | DBMET00219 | |
| 0.059 | 0.174 | 0.091 | Ca(v)3.1 blocker | 0.091 0.034 DBMET00219 | DBMET00219 | |
| 0.029 | 0.145 | 0.065 | Carbonic anhydrase VA inhibitor | 0.065 0.052 DBMET00218 | DBMET00218 | |
| 0.031 | 0.148 | 0.044 | Heme oxygenase inhibitor | 0.044 0.026 DBMET00218 | DBMET00218 | |
| 0.022 | 0.141 | 0.103 | Cannabinoid receptor agonist | 0.103 0.025 DBMET00219 | DBMET00219 | |
| 0.22 | 0.342 | 0.271 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.271 0.255 DBMET00218 | DBMET00218 | |
| 0.025 | 0.149 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.056 DBMET00218 | DBMET00218 | |
| 0.037 | 0.163 | 0.095 | Metalloproteinase-2 inhibitor | 0.095 0.041 DBMET00219 | DBMET00219 | |
| 0.024 | 0.167 | 0.046 | Cathepsin F inhibitor | 0.046 0.018 DBMET00219 | DBMET00219 | |
| 0.031 | 0.175 | 0.067 | Phospholipase D inhibitor | 0.067 0.061 DBMET00218 | DBMET00218 | |
| 0.029 | 0.176 | 0.095 | Carbonic anhydrase XIII inhibitor | 0.095 0.041 DBMET00218 | DBMET00218 | |
| 0.021 | 0.171 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | 0.056 0.036 DBMET00219 | DBMET00219 | |
| 0.079 | 0.243 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.121 0.094 DBMET00219 | DBMET00219 | |
| 0.088 | 0.254 | 0.142 | Pregnane X receptor agonist | 0.142 0.07 DBMET00219 | DBMET00219 | |
| 0.103 | 0.269 | 0.192 | 5 Hydroxytryptamine 1E antagonist | 0.192 0.14 DBMET00218 | DBMET00218 | |
| 0.056 | 0.239 | 0.092 | Glutamate (mGluR7) agonist | 0.092 0.079 DBMET00218 | DBMET00218 | |
| 0.004 | 0.193 | 0.145 | Growth hormone secretagogue receptor agonist | 0.145 0.004 DBMET00219 | DBMET00219 | |
| 0.008 | 0.204 | 0.106 | Secretase gamma inhibitor | 0.106 0.005 DBMET00219 | DBMET00219 | |
| 0.034 | 0.236 | 0.102 | Bcl-xL inhibitor | 0.102 0.006 DBMET00218 | DBMET00218 | |
| 0.069 | 0.292 | 0.134 | Hepatoprotectant | 0.134 0.128 DBMET00218 | DBMET00218 | |
| 0.013 | 0.264 | 0.042 | Liver X receptor alpha agonist | 0.042 0.028 DBMET00219 | DBMET00219 | |
| 0.05 | 0.308 | 0.097 | TRPA1 agonist | 0.097 0.093 DBMET00218 | DBMET00218 | |
| 0.006 | 0.267 | 0.032 | Liver X receptor beta agonist | 0.032 0.024 DBMET00219 | DBMET00219 | |
| 0.031 | 0.294 | 0.144 | M17 leucyl aminopeptidase inhibitor | 0.144 0.06 DBMET00218 | DBMET00218 | |
| 0.082 | 0.351 | 0.184 | 12-Lipoxygenase inhibitor | 0.184 0.169 DBMET00218 | DBMET00218 | |
| 0.09 | 0.377 | 0.241 | 15-Lipoxygenase inhibitor | 0.241 0.172 DBMET00219 | DBMET00219 | |
| 0.085 | 0.409 | 0.287 | Transcription factor inhibitor | 0.25 0.187 DBMET00218 0.287 0.162 DBMET00219 | DBMET00219 | |
| 0.077 | 0.409 | 0.276 | Cholesterol antagonist | 0.276 0.107 DBMET00218 | DBMET00218 | |
| 0.066 | 0.399 | 0.27 | DNA polymerase beta inhibitor | 0.27 0.181 DBMET00219 | DBMET00219 | |
| 0.018 | 0.393 | 0.049 | Glucagon-like peptide 1 receptor antagonist | 0.049 0.014 DBMET00219 | DBMET00219 | |
| 0.049 | 0.458 | 0.22 | Calpain 2 inhibitor | 0.22 0.171 DBMET00218 | DBMET00218 | |
| 0.053 | 0.582 | 0.253 | Nootropic | 0.253 0.105 DBMET00219 | DBMET00219 | |
| 0.008 | 0.544 | 0.085 | Bcl2 antagonist | 0.085 0.028 DBMET00218 | DBMET00218 | |
| 0.007 | 0.606 | 0.037 | Somatostatin 5 agonist | 0.037 0.022 DBMET00218 | DBMET00218 | |
| 0.005 | 0.635 | 0.033 | Liver X receptor antagonist | 0.033 0.019 DBMET00219 | DBMET00219 | |
| 0.003 | 0.662 | 0.045 | Histamine H3 receptor agonist | 0.045 0.012 DBMET00218 | DBMET00218 | |
| 0.004 | 0.674 | 0.028 | Liver X receptor alpha antagonist | 0.028 0.022 DBMET00219 | DBMET00219 | |
| 0.013 | 0.704 | 0.248 | Angiogenesis stimulant | 0.248 0.071 DBMET00218 | DBMET00218 | |
| 0.004 | 0.702 | 0.061 | Liver X receptor agonist | 0.061 0.016 DBMET00219 | DBMET00219 | |
| 0.006 | 0.742 | 0.273 | Mcl-1 antagonist | 0.273 0.028 DBMET00218 | DBMET00218 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |